Data as of Sep 30
| -0.76 / -1.30%|
The 8 analysts offering 12-month price forecasts for AbbVie Inc have a median target of 66.00, with a high estimate of 85.00 and a low estimate of 54.00. The median estimate represents a +14.27% increase from the last price of 57.76.
The current consensus among 13 polled investment analysts is to Buy stock in AbbVie Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.